Fig. 4From: Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literatureClinical course. As a 2nd therapy, weekly paclitaxel (wPTX) without ramucirumab was administered due to hematemesis. Before surgery, the patient experienced a 2nd hematemesis. wPTX weekly paclitaxel; nivo nivolumabBack to article page